These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23318177)

  • 1. Piperlongumine induces inhibition of the ubiquitin-proteasome system in cancer cells.
    Jarvius M; Fryknäs M; D'Arcy P; Sun C; Rickardson L; Gullbo J; Haglund C; Nygren P; Linder S; Larsson R
    Biochem Biophys Res Commun; 2013 Feb; 431(2):117-23. PubMed ID: 23318177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the ubiquitin+proteasome system in solid tumors.
    Driscoll JJ; Woodle ES
    Semin Hematol; 2012 Jul; 49(3):277-83. PubMed ID: 22726552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors.
    Halasi M; Wang M; Chavan TS; Gaponenko V; Hay N; Gartel AL
    Biochem J; 2013 Sep; 454(2):201-8. PubMed ID: 23772801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the ubiquitin proteasome system in haematological malignancies.
    Crawford LJ; Irvine AE
    Blood Rev; 2013 Nov; 27(6):297-304. PubMed ID: 24183816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy.
    Zhao C; Chen X; Zang D; Lan X; Liao S; Yang C; Zhang P; Wu J; Li X; Liu N; Liao Y; Huang H; Shi X; Jiang L; Liu X; He Z; Dou QP; Wang X; Liu J
    Oncogene; 2016 Nov; 35(45):5916-5927. PubMed ID: 27086925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cadmium pyrithione suppresses tumor growth in vitro and in vivo through inhibition of proteasomal deubiquitinase.
    Chen X; Wu J; Yang Q; Zhang X; Zhang P; Liao S; He Z; Wang X; Zhao C; Liu J
    Biometals; 2018 Feb; 31(1):29-43. PubMed ID: 29098502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent reporters for the ubiquitin-proteasome system.
    Salomons FA; Verhoef LG; Dantuma NP
    Essays Biochem; 2005; 41():113-28. PubMed ID: 16250901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
    Gopalan B; Shanker M; Scott A; Branch CD; Chada S; Ramesh R
    Cancer Gene Ther; 2008 Jan; 15(1):1-8. PubMed ID: 17828282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for Inhibitors of the Ubiquitin-Proteasome System from Natural Sources for Cancer Therapy.
    Tsukamoto S
    Chem Pharm Bull (Tokyo); 2016; 64(2):112-8. PubMed ID: 26833439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome deubiquitinases as novel targets for cancer therapy.
    D'Arcy P; Linder S
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1729-38. PubMed ID: 22819849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hinokitiol copper complex inhibits proteasomal deubiquitination and induces paraptosis-like cell death in human cancer cells.
    Chen X; Zhang X; Chen J; Yang Q; Yang L; Xu D; Zhang P; Wang X; Liu J
    Eur J Pharmacol; 2017 Nov; 815():147-155. PubMed ID: 28887042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Proteasomal Deubiquitinase by Silver Complex Induces Apoptosis in Non-Small Cell Lung Cancer Cells.
    Chen X; Yang Q; Chen J; Zhang P; Huang Q; Zhang X; Yang L; Xu D; Zhao C; Wang X; Liu J
    Cell Physiol Biochem; 2018; 49(2):780-797. PubMed ID: 30165348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.
    Vandenberghe I; Créancier L; Vispé S; Annereau JP; Barret JM; Pouny I; Samson A; Aussagues Y; Massiot G; Ausseil F; Bailly C; Kruczynski A
    Biochem Pharmacol; 2008 Aug; 76(4):453-62. PubMed ID: 18577376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of pesticides on proteasome activity: implication in Parkinson's disease.
    Wang XF; Li S; Chou AP; Bronstein JM
    Neurobiol Dis; 2006 Jul; 23(1):198-205. PubMed ID: 16626962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Small Molecules Targeting Ubiquitin-Proteasome System for Cancer Therapy.
    Ao N; Chen Q; Liu G
    Comb Chem High Throughput Screen; 2017; 20(5):403-413. PubMed ID: 28699494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria and ubiquitin-proteasomal system interplay: relevance to Parkinson's disease.
    Domingues AF; Arduíno DM; Esteves AR; Swerdlow RH; Oliveira CR; Cardoso SM
    Free Radic Biol Med; 2008 Sep; 45(6):820-5. PubMed ID: 18619530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
    von Mikecz A; Chen M; Rockel T; Scharf A
    Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future.
    Dalla Via L; Nardon C; Fregona D
    Future Med Chem; 2012 Mar; 4(4):525-43. PubMed ID: 22416778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26 S proteasome.
    Ishii T; Sakurai T; Usami H; Uchida K
    Biochemistry; 2005 Oct; 44(42):13893-901. PubMed ID: 16229478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the ubiquitin proteasome system in neonatal rat gonocytes and spermatogonia: role in gonocyte differentiation.
    Manku G; Wing SS; Culty M
    Biol Reprod; 2012 Aug; 87(2):44. PubMed ID: 22592496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.